The efficacy of ultrasound-guided type-I and type-II pectoral nerve blocks for postoperative analgesia after breast augmentation: A prospective, randomised study

• Published in: Anaesthesia critical care & pain medicine 2019-02, Vol.38 (1), p.47-52
• Main Authors: Karaca, Omer, Pınar, Huseyin U., Arpacı, Enver, Dogan, Rafi, Cok, Oya Y., Ahiskalioglu, Ali
• Format: Article
• Language: English
• Subjects: Adult; Analgesia - methods; Analgesia technique; Analgesia, Patient-Controlled; Analgesics, Opioid - administration & dosage; Anesthetics, Local - administration & dosage; Breast augmentation; Bupivacaine - administration & dosage; Female; Fentanyl - administration & dosage; Humans; Incidence; Length of Stay; Mammaplasty - adverse effects; Mammaplasty - methods; Middle Aged; Nerve Block - adverse effects; Nerve Block - methods; Pain Management - methods; Pain Measurement; Pain, Postoperative - therapy; Pectoral nerves blocks; Postoperative Nausea and Vomiting - epidemiology; Postoperative pain; Prospective Studies; Thoracic Nerves; Ultrasonography, Interventional; Young Adult
• ISSN: 2352-5568; 2352-5568
• DOI: 10.1016/j.accpm.2018.03.009

The present study was planned to evaluate the efficacy and safety of ultrasound-guided Pecs I and II blocks for postoperative analgesia after sub-pectoral breast augmentation. Fifty-four adult female patients undergoing breast augmentation were randomly divided into two groups: the control group (Group C, n=27) who were not subjected to block treatment and Pecs group (Group P, n=27) who received Pecs I (bupivacain 0.25%, 10mL) and Pecs II (bupivacain 0.25%, 20mL) block. Patient-controlled fentanyl analgesia was used for postoperative pain relief in both groups, and the patients were observed for the presence of any block-related complications. The 24-h fentanyl consumption was smaller in Group P [mean±SD, 378.7±54.0μg and 115.7±98.1μg, respectively; P